If this is your company, CONTACT US to activate Packbase™ software to build your portal.
Cristália launches Lunah in Brazilian market
Nemera breaks ground in Brazil through Milfra acquisition
Nemera's RetroNose enhances therapeutic efficacy of nasal treatments- Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosopt for Glaucoma treatments
- e-Novelia wins the ‘Excellence in Pharma: Drug Delivery Devices’ award at CPhI Worldwide 2018
- New: Twisting applicator for Sof’Bag by Nemera
- Nemera's Safe'n'Sound responds to pharma and user needs
- Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany
- Nemera announces its participation in the European Cupido Project
Safelia 1ml and 2.25ml autoinjectors designed to be patient and syringe friendly- The UK has approved a new drug product for glaucoma treatment, delivered with Novelia, Nemera's multidose preservative-free eyedropper
- Novelia is now commercialized for the first time for glaucoma in Latin America!
- A new 70 µl dose is available for the SP270+ pump!
- Nemera has won the ‘Best New Product’ category at the annual INTERPHEX Awards
